Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: Amigo Mike who wrote (803)	3/31/1998 11:04:00 PM
From: Joseph Wisnowski	Respond to of 1476

Mike; Yes, I have stopped by your site... gotta love that tune, almost as good as a polka. I have to admire your confidence and enthusiasm in this co. I have been in small cap pharms for some time and have done quite well, but I do remember the stinkers, so I do proceed with a certain amount of caution. I think I'll do some share analysis with the split combos and try to project some future earnings to see if I should throw in additional funds. Joe W.

To: Amigo Mike who wrote (803)	4/3/1998 1:35:00 PM
From: BK	Read Replies (2) \| Respond to of 1476

This was posted over on the Yahoo thread. If anyone can provide details, I would appreciate it. I have been trying to find this info in the SEC/NASDAQ sections, but without much luck. If you know a place to get this info, would appreciate a post here. TIA. "With the new NASDAQ rules, what are the price and volume requirements required for margin buying? Under previous rules the requirements were different from the listing requirements. This is recognized to be an important element in maintaining daily trading volume and avoiding slippage due to a somnolent market. Would the Antex reverse split proposal meet these requirements as well? "